Adcock Ingram to Delist Amidst Corporate Changes

Adcock Ingram is set to delist from the JSE as Natco Pharma partners with Bidvest in a major take-private deal.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Tagged Adcock Ingram, Bidvest, Corporate News, healthcare, Johannesburg Stock Exchange, JSE, Mergers & Acquisitions, Natco Pharma, Panado, pharmaceuticals, South African Business